Volume 2, Issue 2

Clinical Markers for MS Diagnosis and Prognosis

In this issue:

The central vein sign. Optical coherence tomography. Serum neurofilament light chain. New research has identified these markers as valuable in discriminating MS from mimicking conditions, and in predicting future disability.

In this Issue, Dr. Michael Kornberg and Dr. Elias Sotirchos from the Johns Hopkins University School of Medicine discuss how these advances can impact clinical decision-making to provide better patient care.

Learning objectives:

  • Discuss the role of emerging biomarkers, including optical coherence tomography and serum neurofilament light chain, in predicting future disability in MS.
  • Describe the potential use of the central vein sign in discriminating MS from mimicking conditions.

Authors:

Elias Sotirchos, MD
Elias Sotirchos, MD

Post-Doctoral Fellow
Department of Neurology
Johns Hopkins University School of Medicine
Baltimore, MD

Michael Kornberg, MD, PhD
Michael Kornberg, MD, PhD

Assistant Professor
Department of Neurology
Johns Hopkins University School of Medicine
Baltimore, MD

Program Director:

Michael Kornberg, MD, PhD

Assistant Professor
Department of Neurology
Johns Hopkins University School of Medicine
Baltimore, MD

Length of activity:

0.5 hour Physicians

Launch date: February 25, 2019
Expiration date: February 24, 2021